Increased incidence of Parkinson disease among relatives of patients with Gaucher disease
- PMID: 16651014
- DOI: 10.1016/j.bcmd.2006.02.004
Increased incidence of Parkinson disease among relatives of patients with Gaucher disease
Abstract
In a previous study of 99 Ashkenazi Jewish patients with Parkinson disease from Israel who were tested for the six most common mutations for Gaucher disease, 31.3% had at least one Gaucher disease mutation, implying that carrier status per se my be a risk for Parkinson disease. The purpose of this survey was to ascertain the presence of Parkinson disease among Ashkenazi Jewish obligate carriers of Gaucher disease relative to its incidence in a comparable cohort of Ashkenazi Jews who are putatively non-carriers. There was no statistically significant difference in gender or age between the groups (n>100). Among patients, 27.3% reported having a relative with Parkinson disease while among the controls there was a reported 12.3% which was statistically significant (P=0.05). While based completely on subjective reports in a paper-base questionnaire, the results of this survey implicate a high rate of Parkinson disease among individuals with Gaucher disease mutations.
Similar articles
-
Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.Hum Mutat. 1998;12(4):240-4. doi: 10.1002/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J. Hum Mutat. 1998. PMID: 9744474
-
Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.Mov Disord. 2011 Jun;26(7):1341-3. doi: 10.1002/mds.23595. Epub 2011 Apr 5. Mov Disord. 2011. PMID: 21469198
-
[Frequency of the Gaucher mutation among recent Russian immigrants].Harefuah. 1995 Jun 15;128(12):757-8, 824. Harefuah. 1995. PMID: 7557682 Hebrew.
-
Gaucher disease: complexity in a "simple" disorder.Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15. doi: 10.1016/j.ymgme.2004.08.015. Mol Genet Metab. 2004. PMID: 15464415 Review.
-
Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.Isr Med Assoc J. 2006 May;8(5):347-50. Isr Med Assoc J. 2006. PMID: 16805236 Review.
Cited by
-
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.Autophagy. 2022 May;18(5):1127-1151. doi: 10.1080/15548627.2022.2045534. Epub 2022 Apr 28. Autophagy. 2022. PMID: 35287553 Free PMC article.
-
Lysosomal storage diseases.Transl Sci Rare Dis. 2017 May 25;2(1-2):1-71. doi: 10.3233/TRD-160005. Transl Sci Rare Dis. 2017. PMID: 29152458 Free PMC article. Review.
-
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.Biomolecules. 2023 Apr 3;13(4):644. doi: 10.3390/biom13040644. Biomolecules. 2023. PMID: 37189391 Free PMC article.
-
79-year old man with Parkinsonism and acute spinal cord compression.Brain Pathol. 2014 Jan;24(1):101-2. doi: 10.1111/bpa.12106. Brain Pathol. 2014. PMID: 24345224 Free PMC article. No abstract available.
-
Genetics of Parkinson's disease - a clinical perspective.J Mov Disord. 2012 Oct;5(2):33-41. doi: 10.14802/jmd.12009. Epub 2012 Oct 30. J Mov Disord. 2012. PMID: 24868412 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical